136 related articles for article (PubMed ID: 4438990)
1. [Clinical trial of tibric acid, a new hypolipidemic agent].
Noseda G; Sirtori CR
Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
[No Abstract] [Full Text] [Related]
2. [Treatment of hyperlipidemia with a new drug, tibric acid].
Carmena R; González R Florez J; Sanchis J
Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of tibric acid (CP 18,524) a new hypolipidemic agent.
Sirtori CR; Zoppi S; Quarisa B; Agradi E
Pharmacol Res Commun; 1974 Oct; 6(5):445-56. PubMed ID: 4617230
[No Abstract] [Full Text] [Related]
4. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
Lisch HJ; Sailer S; Braunsteiner H
Arzneimittelforschung; 1977; 27(10):2017-20. PubMed ID: 579116
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trials with Fonlipol. Apropos of 50 cases].
Warembourg H; Jaillard J
Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
[No Abstract] [Full Text] [Related]
6. [Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects].
Bielmann P; Annable L; Brun D; Moorjani S; Lupien PJ; Tétreault L
Union Med Can; 1975 Jun; 104(6):930-4. PubMed ID: 1224412
[No Abstract] [Full Text] [Related]
7. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
Fourrier A; Mouton Y
Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
[No Abstract] [Full Text] [Related]
8. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
Rouffy J; Dreux C; Goussault Y; Dakkak R; Renson FJ
Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
[TBL] [Abstract][Full Text] [Related]
9. [Hyperlipemia and pancreatitis].
Carrillo Penso N; Carrasquero O; Medina JA
G E N; 1981; 35(1-2):15-27. PubMed ID: 6816659
[No Abstract] [Full Text] [Related]
10. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
Warembourg H; Ketelers JY; Ginestet A
Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
[No Abstract] [Full Text] [Related]
11. [Current trends in the therapy of arteriosclerotic disease].
Toscano S
G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
[No Abstract] [Full Text] [Related]
12. Does hypolipidemic therapy prevent coronary heart disease?
Rifkind BM; Levy RI
Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
[No Abstract] [Full Text] [Related]
13. [Clinical experimentation of clofibride. Apropos of 40 cases].
Warembourg H; Jaillard J
Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
[No Abstract] [Full Text] [Related]
14. The primary hyperlipoproteinemias.
Bybee DE; Hamilton RD
J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
[No Abstract] [Full Text] [Related]
15. Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
Smith FR; Noble RP; Goodman DS
Atherosclerosis; 1978 Mar; 29(3):345-54. PubMed ID: 666884
[No Abstract] [Full Text] [Related]
16. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
[No Abstract] [Full Text] [Related]
17. Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemia.
Bielmann P; Brun D; Moorjani S; Gagné C; Lupien P; Tétreault L
Clin Pharmacol Ther; 1975 May; 17(5):606-11. PubMed ID: 165029
[TBL] [Abstract][Full Text] [Related]
18. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
Weiss P; Bianchine JR
Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
[No Abstract] [Full Text] [Related]
19. Diagnosis and management of hyperlipidemia.
Palumbo PJ
Compr Ther; 1978 Oct; 4(10):33-9. PubMed ID: 359229
[No Abstract] [Full Text] [Related]
20. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
